{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:46:07Z","timestamp":1792190767425,"version":"4.4.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finantial Code 001"],"award-info":[{"award-number":["Finantial Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Researcher fellow 1B (BPP 306037\/2019-0)"],"award-info":[{"award-number":["Researcher fellow 1B (BPP 306037\/2019-0)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Researcher fellow 1D (311539\/2020-3)"],"award-info":[{"award-number":["Researcher fellow 1D (311539\/2020-3)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["CNE-E-26\/ 210.190\/2018"],"award-info":[{"award-number":["CNE-E-26\/ 210.190\/2018"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["JCNE-E-26\/203.031\/2018"],"award-info":[{"award-number":["JCNE-E-26\/203.031\/2018"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the heart tissue of acutely <jats:italic>Trypanosoma cruzi<\/jats:italic>-infected mice miR-145-5p and miR-146b-5p are, respectively, downregulated and upregulated. Here, we used the H9C2 rat cardiomyoblast cell line infected with the Colombian <jats:italic>T. cruzi<\/jats:italic> strain to investigate the parasite-host cell interplay, focusing on the regulation of miR-145-5p and miR-146b-5p expression. Next, we explored the effects of interventions with the trypanosomicidal drug Benznidazole (Bz) alone or combined with Pentoxifylline (PTX), a methylxanthine derivative shown to modulate immunological and cardiac abnormalities in a model of chronic chagasic cardiomyopathy, on parasite load and expression of miR-145-5p and miR-146b-5p. The infection of H9C2 cells with trypomastigote forms allowed parasite cycle with intracellular forms multiplication and trypomastigote release. After 48 and 144\u00a0h of infection, upregulation of miR-145-5p (24\u00a0h: 2.38\u2009\u00b1\u20090.26; 48\u00a0h: 3.15\u2009\u00b1\u20090.9-fold change) and miR-146b-5b (24\u00a0h: 2.60\u2009\u00b1\u20090.46; 48\u00a0h: 2.97\u2009\u00b1\u20090.23-fold change) was detected. The peak of both miRNA levels paralleled with release of trypomastigote forms. Addition of 3\u00a0\u00b5M and 10\u00a0\u00b5M of Bz 48\u00a0h after infection reduced parasite load but did not interfere with miR-145-5p and miR-146b-5p levels. Addition of PTX did not interfere with Bz-induced parasite control efficacy. Conversely, combined Bz\u2009+\u2009PTX treatment decreased the levels of both microRNAs, resembling the expression levels detected in non-infected H9C2 cells. Moreover, the use of miR-145-5p and miR-146b-5p mimic\/inhibitor systems before infection of H9C2 cells decreased parasite load, 72\u00a0h postinfection. When H9C2 cells were treated with miR-145-5p and miR-146b-5p mimic\/inhibitor 48\u00a0h after infection, all the used systems, except the miR-146b-5p inhibitor, reduced parasite load. Altogether, our data indicate that these microRNAs putatively control signaling pathways crucial for parasite\u2013host cell interaction. Thus, miR-145-5p and miR-146b-5p deserve to be further investigated as biomarkers of parasite control and tools to identify therapeutic adjuvants to etiological treatment in Chagas disease.<\/jats:p>","DOI":"10.1038\/s41598-022-05493-4","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T11:02:34Z","timestamp":1643194954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts"],"prefix":"10.1038","volume":"12","author":[{"given":"Priscila Silva Grij\u00f3","family":"Farani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Iandra Silva","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseli","family":"Lannes-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otacilio Cruz","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"5493_CR1","unstructured":"WHO. Chagas disease (American trypanosomiasis). https:\/\/www.who.int\/health-topics\/chagas-disease# (2021)."},{"key":"5493_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.actatropica.2013.10.002","volume":"130","author":"FR Martins-Melo","year":"2014","unstructured":"Martins-Melo, F. R., Ramos, A. N. Jr., Alencar, C. H. & Heukelbach, J. Prevalence of Chagas disease in Brazil: A systematic review and meta-analysis. Acta Trop. 130, 167\u2013174. https:\/\/doi.org\/10.1016\/j.actatropica.2013.10.002 (2014).","journal-title":"Acta Trop."},{"key":"5493_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.idc.2012.03.002","volume":"26","author":"A Rassi Jr","year":"2012","unstructured":"Rassi, A. Jr., Rassi, A. & Marcondes de Rezende, J. American trypanosomiasis (Chagas disease). Infect. Dis. Clin. North Am. 26, 275\u2013291. https:\/\/doi.org\/10.1016\/j.idc.2012.03.002 (2012).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"5493_CR4","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","volume":"138","author":"MCP Nunes","year":"2018","unstructured":"Nunes, M. C. P. et al. Chagas cardiomyopathy: An update of current clinical knowledge and management: A scientific statement from the American Heart Association. Circulation 138, e169\u2013e209. https:\/\/doi.org\/10.1161\/CIR.0000000000000599 (2018).","journal-title":"Circulation"},{"key":"5493_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/683230","volume":"2014","author":"E Cunha-Neto","year":"2014","unstructured":"Cunha-Neto, E. & Chevillard, C. Chagas disease cardiomyopathy: Immunopathology and genetics. Mediat. Inflamm. 2014, 683230. https:\/\/doi.org\/10.1155\/2014\/683230 (2014).","journal-title":"Mediat. Inflamm."},{"key":"5493_CR6","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1056\/NEJMct1014204","volume":"364","author":"C Bern","year":"2011","unstructured":"Bern, C. Antitrypanosomal therapy for chronic Chagas\u2019 disease. N. Engl. J. Med. 364, 2527\u20132534. https:\/\/doi.org\/10.1056\/NEJMct1014204 (2011).","journal-title":"N. Engl. J. Med."},{"key":"5493_CR7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/17512433.2018.1509704","volume":"11","author":"JM Kratz","year":"2018","unstructured":"Kratz, J. M., Garcia Bournissen, F., Forsyth, C. J. & Sosa-Estani, S. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease. Expert Rev. Clin. Pharmacol. 11, 943\u2013957. https:\/\/doi.org\/10.1080\/17512433.2018.1509704 (2018).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"5493_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/em.21839","volume":"55","author":"MA Rajao","year":"2014","unstructured":"Rajao, M. A. et al. Unveiling benznidazole\u2019s mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi. Environ. Mol. Mutagen 55, 309\u2013321. https:\/\/doi.org\/10.1002\/em.21839 (2014).","journal-title":"Environ. Mol. Mutagen"},{"key":"5493_CR9","unstructured":"FDA. Novel Drug Approvals for 2020. (2020)."},{"key":"5493_CR10","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1128\/AAC.05018-14","volume":"59","author":"D Soy","year":"2015","unstructured":"Soy, D. et al. Population pharmacokinetics of benznidazole in adult patients with Chagas disease. Antimicrob. Agents Chemother. 59, 3342\u20133349. https:\/\/doi.org\/10.1128\/AAC.05018-14 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5493_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpddr.2015.12.001","volume":"6","author":"AC Cevey","year":"2016","unstructured":"Cevey, A. C., Mirkin, G. A., Penas, F. N. & Goren, N. B. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain. Int. J. Parasitol. Drugs Drug Resist. 6, 12\u201322. https:\/\/doi.org\/10.1016\/j.ijpddr.2015.12.001 (2016).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"5493_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2020.108061","volume":"221","author":"LF de Almeida Fiuza","year":"2021","unstructured":"de Almeida Fiuza, L. F. et al. Benznidazole modulates release of inflammatory mediators by cardiac spheroids infected with Trypanosoma cruzi. Exp. Parasitol. 221, 108061. https:\/\/doi.org\/10.1016\/j.exppara.2020.108061 (2021).","journal-title":"Exp. Parasitol."},{"key":"5493_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40409-017-0137-4","volume":"23","author":"M Gatto","year":"2017","unstructured":"Gatto, M. et al. Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection. J. Venom. Anim. Toxins Incl. Trop. Dis. 23, 47. https:\/\/doi.org\/10.1186\/s40409-017-0137-4 (2017).","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"5493_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.molimm.2010.12.021","volume":"48","author":"MT Ronco","year":"2011","unstructured":"Ronco, M. T. et al. Benznidazole treatment attenuates liver NF-kappaB activity and MAPK in a cecal ligation and puncture model of sepsis. Mol. Immunol. 48, 867\u2013873. https:\/\/doi.org\/10.1016\/j.molimm.2010.12.021 (2011).","journal-title":"Mol. Immunol."},{"key":"5493_CR15","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1128\/AAC.02123-15","volume":"60","author":"G Vilar-Pereira","year":"2016","unstructured":"Vilar-Pereira, G. et al. Combination chemotherapy with suboptimal doses of benznidazole and pentoxifylline sustains partial reversion of experimental Chagas\u2019 heart disease. Antimicrob. Agents Chemother. 60, 4297\u20134309. https:\/\/doi.org\/10.1128\/AAC.02123-15 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5493_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2015-000365","volume":"3","author":"MF McCarty","year":"2016","unstructured":"McCarty, M. F., O\u2019Keefe, J. H. & DiNicolantonio, J. J. Pentoxifylline for vascular health: A brief review of the literature. Open Heart 3, e000365. https:\/\/doi.org\/10.1136\/openhrt-2015-000365 (2016).","journal-title":"Open Heart"},{"key":"5493_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s0140-6736(97)09338-0","volume":"351","author":"K Sliwa","year":"1998","unstructured":"Sliwa, K., Skudicky, D., Candy, G., Wisenbaugh, T. & Sareli, P. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 351, 1091\u20131093. https:\/\/doi.org\/10.1016\/s0140-6736(97)09338-0 (1998).","journal-title":"Lancet"},{"key":"5493_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/01.CIR.0000112568.48837.60","volume":"109","author":"K Sliwa","year":"2004","unstructured":"Sliwa, K. et al. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: Results of a randomized study. Circulation 109, 750\u2013755. https:\/\/doi.org\/10.1161\/01.CIR.0000112568.48837.60 (2004).","journal-title":"Circulation"},{"key":"5493_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003659","volume":"9","author":"IR Pereira","year":"2015","unstructured":"Pereira, I. R. et al. Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response. PLoS Negl. Trop. Dis. 9, e0003659. https:\/\/doi.org\/10.1371\/journal.pntd.0003659 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5493_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215\u2013233. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002 (2009).","journal-title":"Cell"},{"key":"5493_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nbt0607-631","volume":"25","author":"GS Mack","year":"2007","unstructured":"Mack, G. S. MicroRNA gets down to business. Nat. Biotechnol. 25, 631\u2013638. https:\/\/doi.org\/10.1038\/nbt0607-631 (2007).","journal-title":"Nat. Biotechnol."},{"key":"5493_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1590\/1414-431x20142937","volume":"47","author":"HJ Feng","year":"2014","unstructured":"Feng, H. J. et al. Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy. Braz. J. Med. Biol. Res. 47, 361\u2013368. https:\/\/doi.org\/10.1590\/1414-431x20142937 (2014).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"5493_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/cvr\/cvs013","volume":"93","author":"PA Da Costa Martins","year":"2012","unstructured":"Da Costa Martins, P. A. & De Windt, L. J. MicroRNAs in control of cardiac hypertrophy. Cardiovasc. Res. 93, 563\u2013572. https:\/\/doi.org\/10.1093\/cvr\/cvs013 (2012).","journal-title":"Cardiovasc. Res."},{"key":"5493_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.4161\/rna.20018","volume":"9","author":"A Eulalio","year":"2012","unstructured":"Eulalio, A., Schulte, L. & Vogel, J. The mammalian microRNA response to bacterial infections. RNA Biol. 9, 742\u2013750. https:\/\/doi.org\/10.4161\/rna.20018 (2012).","journal-title":"RNA Biol."},{"key":"5493_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1742-4690-3-68","volume":"3","author":"V Scaria","year":"2006","unstructured":"Scaria, V., Hariharan, M., Maiti, S., Pillai, B. & Brahmachari, S. K. Host\u2013virus interaction: A new role for microRNAs. Retrovirology 3, 68. https:\/\/doi.org\/10.1186\/1742-4690-3-68 (2006).","journal-title":"Retrovirology"},{"key":"5493_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.micro.112408.134243","volume":"64","author":"RL Skalsky","year":"2010","unstructured":"Skalsky, R. L. & Cullen, B. R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64, 123\u2013141. https:\/\/doi.org\/10.1146\/annurev.micro.112408.134243 (2010).","journal-title":"Annu. Rev. Microbiol."},{"key":"5493_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.pt.2011.07.001","volume":"27","author":"MA Hakimi","year":"2011","unstructured":"Hakimi, M. A. & Cannella, D. Apicomplexan parasites and subversion of the host cell microRNA pathway. Trends Parasitol. 27, 481\u2013486. https:\/\/doi.org\/10.1016\/j.pt.2011.07.001 (2011).","journal-title":"Trends Parasitol."},{"key":"5493_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002478","volume":"7","author":"J Lemaire","year":"2013","unstructured":"Lemaire, J. et al. MicroRNA expression profile in human macrophages in response to Leishmania major infection. PLoS Negl. Trop. Dis. 7, e2478. https:\/\/doi.org\/10.1371\/journal.pntd.0002478 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5493_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008742","volume":"5","author":"GM Zeiner","year":"2010","unstructured":"Zeiner, G. M., Norman, K. L., Thomson, J. M., Hammond, S. M. & Boothroyd, J. C. Toxoplasma gondii infection specifically increases the levels of key host microRNAs. PLoS\u00a0One 5, e8742. https:\/\/doi.org\/10.1371\/journal.pone.0008742 (2010).","journal-title":"PLoS\u00a0One"},{"key":"5493_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fmicb.2016.00367","volume":"7","author":"L Linhares-Lacerda","year":"2016","unstructured":"Linhares-Lacerda, L. & Morrot, A. Role of small RNAs in trypanosomatid infections. Front. Microbiol. 7, 367. https:\/\/doi.org\/10.3389\/fmicb.2016.00367 (2016).","journal-title":"Front. Microbiol."},{"key":"5493_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008889","volume":"14","author":"L Laugier","year":"2020","unstructured":"Laugier, L. et al. miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy. PLoS Negl. Trop. Dis. 14, e0008889. https:\/\/doi.org\/10.1371\/journal.pntd.0008889 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5493_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijcard.2014.05.019","volume":"175","author":"LR Ferreira","year":"2014","unstructured":"Ferreira, L. R. et al. MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in chronic Chagas disease cardiomyopathy. Int. J. Cardiol. 175, 409\u2013417. https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.019 (2014).","journal-title":"Int. J. Cardiol."},{"key":"5493_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003828","volume":"9","author":"IC Navarro","year":"2015","unstructured":"Navarro, I. C. et al. MicroRNA transcriptome profiling in heart of Trypanosoma cruzi-infected mice: Parasitological and cardiological outcomes. PLoS Negl. Trop. Dis. 9, e0003828. https:\/\/doi.org\/10.1371\/journal.pntd.0003828 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5493_CR34","doi-asserted-by":"publisher","first-page":"17990","DOI":"10.1038\/s41598-017-18080-9","volume":"7","author":"LRP Ferreira","year":"2017","unstructured":"Ferreira, L. R. P. et al. Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection. Sci. Rep. 7, 17990. https:\/\/doi.org\/10.1038\/s41598-017-18080-9 (2017).","journal-title":"Sci. Rep."},{"key":"5493_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fimmu.2015.00428","volume":"6","author":"L Linhares-Lacerda","year":"2015","unstructured":"Linhares-Lacerda, L. et al. Differential expression of microRNAs in thymic epithelial cells from Trypanosoma cruzi acutely infected mice: Putative role in thymic atrophy. Front. Immunol. 6, 428. https:\/\/doi.org\/10.3389\/fimmu.2015.00428 (2015).","journal-title":"Front. Immunol."},{"key":"5493_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fmicb.2018.00269","volume":"9","author":"L Linhares-Lacerda","year":"2018","unstructured":"Linhares-Lacerda, L. et al. Circulating plasma microRNA-208a as potential biomarker of chronic indeterminate phase of Chagas disease. Front. Microbiol. 9, 269. https:\/\/doi.org\/10.3389\/fmicb.2018.00269 (2018).","journal-title":"Front. Microbiol."},{"key":"5493_CR37","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.3390\/ijms20164064","volume":"20","author":"CKV Nonaka","year":"2019","unstructured":"Nonaka, C. K. V. et al. Circulating miRNAs as potential biomarkers associated with cardiac remodeling and fibrosis in Chagas disease cardiomyopathy. Int. J. Mol. Sci. 20, 4064. https:\/\/doi.org\/10.3390\/ijms20164064 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"5493_CR38","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/jcmm.12358","volume":"18","author":"SY Cui","year":"2014","unstructured":"Cui, S. Y., Wang, R. & Chen, L. B. MicroRNA-145: A potent tumour suppressor that regulates multiple cellular pathways. J. Cell. Mol. Med. 18, 1913\u20131926. https:\/\/doi.org\/10.1111\/jcmm.12358 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"5493_CR39","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1530\/VB-20-0012","volume":"2","author":"D Sawant","year":"2020","unstructured":"Sawant, D. & Lilly, B. MicroRNA-145 targets in cancer and the cardiovascular system: Evidence for common signaling pathways. Vasc. Biol. 2, R115\u2013R128. https:\/\/doi.org\/10.1530\/VB-20-0012 (2020).","journal-title":"Vasc. Biol."},{"key":"5493_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.yjmcc.2013.08.007","volume":"66","author":"YS Wang","year":"2014","unstructured":"Wang, Y. S. et al. Role of miR-145 in cardiac myofibroblast differentiation. J. Mol. Cell. Cardiol. 66, 94\u2013105. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.08.007 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"5493_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/00365513.2014.981855","volume":"75","author":"YM Dong","year":"2015","unstructured":"Dong, Y. M. et al. Prediction of long-term outcome after acute myocardial infarction using circulating miR-145. Scand. J. Clin. Lab. Investig. 75, 85\u201391. https:\/\/doi.org\/10.3109\/00365513.2014.981855 (2015).","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"5493_CR42","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103, 12481\u201312486. https:\/\/doi.org\/10.1073\/pnas.0605298103 (2006).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"5493_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1152\/physiolgenomics.00133.2016","volume":"49","author":"MR Paterson","year":"2017","unstructured":"Paterson, M. R. & Kriegel, A. J. MiR-146a\/b: A family with shared seeds and different roots. Physiol. Genomics 49, 243\u2013252. https:\/\/doi.org\/10.1152\/physiolgenomics.00133.2016 (2017).","journal-title":"Physiol. Genomics"},{"key":"5493_CR44","first-page":"737","volume":"19","author":"RK Kutty","year":"2013","unstructured":"Kutty, R. K. et al. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1\u03b2, tumor necrosis factor-\u03b1, and interferon-\u03b3. Mol. Vis. 19, 737\u2013750 (2013).","journal-title":"Mol. Vis."},{"key":"5493_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/798078","volume":"2014","author":"IR Pereira","year":"2014","unstructured":"Pereira, I. R. et al. Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas\u2019 heart disease. Mediat. Inflamm. 2014, 798078. https:\/\/doi.org\/10.1155\/2014\/798078 (2014).","journal-title":"Mediat. Inflamm."},{"key":"5493_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s0002-9440(10)62976-8","volume":"167","author":"E Cunha-Neto","year":"2005","unstructured":"Cunha-Neto, E. et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas\u2019 disease cardiomyopathy. Am. J. Pathol. 167, 305\u2013313. https:\/\/doi.org\/10.1016\/s0002-9440(10)62976-8 (2005).","journal-title":"Am. J. Pathol."},{"issue":"Suppl 1","key":"5493_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/s0074-02762009000900032","volume":"104","author":"E Cunha-Neto","year":"2009","unstructured":"Cunha-Neto, E. et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem. Inst. Oswaldo Cruz 104(Suppl 1), 252\u2013258. https:\/\/doi.org\/10.1590\/s0074-02762009000900032 (2009).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"5493_CR48","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.hrthm.2015.01.026","volume":"12","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Integrated analysis of microRNA and mRNA expression profiles in the left atrium of patients with nonvalvular paroxysmal atrial fibrillation: Role of miR-146b-5p in atrial fibrosis. Heart Rhythm 12, 1018\u20131026. https:\/\/doi.org\/10.1016\/j.hrthm.2015.01.026 (2015).","journal-title":"Heart Rhythm"},{"key":"5493_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"D Fan","year":"2012","unstructured":"Fan, D., Takawale, A., Lee, J. & Kassiri, Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 5, 15. https:\/\/doi.org\/10.1186\/1755-1536-5-15 (2012).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"5493_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/CS20100003","volume":"119","author":"Y Takahashi","year":"2010","unstructured":"Takahashi, Y. et al. Expression of miR-146a\/b is associated with the Toll-like receptor 4 signal in coronary artery disease: Effect of renin-angiotensin system blockade and statins on miRNA-146a\/b and Toll-like receptor 4 levels. Clin. Sci. (Lond.) 119, 395\u2013405. https:\/\/doi.org\/10.1042\/CS20100003 (2010).","journal-title":"Clin. Sci. (Lond.)"},{"key":"5493_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s13238-020-00750-6","volume":"12","author":"Y Liao","year":"2021","unstructured":"Liao, Y. et al. Therapeutic silencing miR-146b-5p improves cardiac remodeling in a porcine model of myocardial infarction by modulating the wound reparative phenotype. Protein Cell 12, 194\u2013212. https:\/\/doi.org\/10.1007\/s13238-020-00750-6 (2021).","journal-title":"Protein Cell"},{"key":"5493_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1128\/aem.60.1.149-152.1994","volume":"60","author":"FJ van Kuppeveld","year":"1994","unstructured":"van Kuppeveld, F. J. et al. Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Appl. Environ. Microbiol. 60, 149\u2013152. https:\/\/doi.org\/10.1128\/aem.60.1.149-152.1994 (1994).","journal-title":"Appl. Environ. Microbiol."},{"key":"5493_CR53","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/AEM.58.8.2606-2615.1992","volume":"58","author":"FJ van Kuppeveld","year":"1992","unstructured":"van Kuppeveld, F. J. et al. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl. Environ. Microbiol. 58, 2606\u20132615. https:\/\/doi.org\/10.1128\/AEM.58.8.2606-2615.1992 (1992).","journal-title":"Appl. Environ. Microbiol."},{"key":"5493_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","volume":"184","author":"B Zingales","year":"2018","unstructured":"Zingales, B. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity. Acta Trop. 184, 38\u201352. https:\/\/doi.org\/10.1016\/j.actatropica.2017.09.017 (2018).","journal-title":"Acta Trop."},{"key":"5493_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4 (1983).","journal-title":"J. Immunol. Methods"},{"key":"5493_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002000","volume":"7","author":"T Duffy","year":"2013","unstructured":"Duffy, T. et al. Analytical performance of a multiplex Real-Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl. Trop. Dis. 7, e2000. https:\/\/doi.org\/10.1371\/journal.pntd.0002000 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5493_CR57","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jmoldx.2015.04.010","volume":"17","author":"JC Ramirez","year":"2015","unstructured":"Ramirez, J. C. et al. Analytical validation of quantitative real-time PCR methods for quantification of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. J. Mol. Diagn. 17, 605\u2013615. https:\/\/doi.org\/10.1016\/j.jmoldx.2015.04.010 (2015).","journal-title":"J. Mol. Diagn."},{"key":"5493_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"5493_CR59","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108. https:\/\/doi.org\/10.1038\/nprot.2008.73 (2008).","journal-title":"Nat. Protoc."},{"key":"5493_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1381612023396276","volume":"8","author":"W De Souza","year":"2002","unstructured":"De Souza, W. Basic cell biology of Trypanosoma cruzi. Curr. Pharm. Des. 8, 269\u2013285. https:\/\/doi.org\/10.2174\/1381612023396276 (2002).","journal-title":"Curr. Pharm. Des."},{"key":"5493_CR61","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11596-016-1594-7","volume":"36","author":"H Li","year":"2016","unstructured":"Li, H. et al. Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway. J. Huazhong Univ. Sci. Technol. Med. Sci. 36, 372\u2013376. https:\/\/doi.org\/10.1007\/s11596-016-1594-7 (2016).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"5493_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.burns.2005.08.004","volume":"32","author":"JM Rawlins","year":"2006","unstructured":"Rawlins, J. M., Lam, W. L., Karoo, R. O., Naylor, I. L. & Sharpe, D. T. Pentoxifylline inhibits mature burn scar fibroblasts in culture. Burns 32, 42\u201345. https:\/\/doi.org\/10.1016\/j.burns.2005.08.004 (2006).","journal-title":"Burns"},{"key":"5493_CR63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s0140-6736(17)31612-4","volume":"391","author":"JA P\u00e9rez-Molina","year":"2018","unstructured":"P\u00e9rez-Molina, J. A. & Molina, I. Chagas disease. Lancet 391, 82\u201394. https:\/\/doi.org\/10.1016\/s0140-6736(17)31612-4 (2018).","journal-title":"Lancet"},{"key":"5493_CR64","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1590\/0074-02760150184","volume":"110","author":"CJ Monteiro","year":"2015","unstructured":"Monteiro, C. J., Mota, S. L., Diniz Lde, F., Bahia, M. T. & Moraes, K. C. Mir-190b negatively contributes to the Trypanosoma cruzi-infected cell survival by repressing PTEN protein expression. Mem. Inst. Oswaldo Cruz 110, 996\u20131002. https:\/\/doi.org\/10.1590\/0074-02760150184 (2015).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"5493_CR65","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4269\/ajtmh.1993.48.637","volume":"48","author":"DD Reis","year":"1993","unstructured":"Reis, D. D. et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: Presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 48, 637\u2013644. https:\/\/doi.org\/10.4269\/ajtmh.1993.48.637 (1993).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"5493_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118600","volume":"10","author":"RR Silva","year":"2015","unstructured":"Silva, R. R. et al. Interferon-gamma promotes infection of astrocytes by Trypanosoma cruzi. PLoS\u00a0One 10, e0118600. https:\/\/doi.org\/10.1371\/journal.pone.0118600 (2015).","journal-title":"PLoS\u00a0One"},{"key":"5493_CR67","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-017-0952-0","volume":"14","author":"AA Silva","year":"2017","unstructured":"Silva, A. A. et al. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu. J. Neuroinflamm. 14, 182. https:\/\/doi.org\/10.1186\/s12974-017-0952-0 (2017).","journal-title":"J. Neuroinflamm."},{"key":"5493_CR68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","volume":"47","author":"SJ Watkins","year":"2011","unstructured":"Watkins, S. J., Borthwick, G. M. & Arthur, H. M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell. Dev. Biol. Anim. 47, 125\u2013131. https:\/\/doi.org\/10.1007\/s11626-010-9368-1 (2011).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"5493_CR69","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fimmu.2012.00327","volume":"3","author":"CM Calvet","year":"2012","unstructured":"Calvet, C. M. et al. Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction. Front. Immunol. 3, 327. https:\/\/doi.org\/10.3389\/fimmu.2012.00327 (2012).","journal-title":"Front. Immunol."},{"key":"5493_CR70","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.pt.2015.06.006","volume":"31","author":"CJ Perez","year":"2015","unstructured":"Perez, C. J., Lymbery, A. J. & Thompson, R. C. A. Reactivation of chagas disease: Implications for global health. Trends Parasitol. 31, 595\u2013603. https:\/\/doi.org\/10.1016\/j.pt.2015.06.006 (2015).","journal-title":"Trends Parasitol."},{"key":"5493_CR71","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","volume":"49","author":"S Garcia","year":"2005","unstructured":"Garcia, S. et al. Treatment with benznidazole during the chronic phase of experimental Chagas\u2019 disease decreases cardiac alterations. Antimicrob. Agents Chemother. 49, 1521\u20131528. https:\/\/doi.org\/10.1128\/AAC.49.4.1521-1528.2005 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5493_CR72","doi-asserted-by":"publisher","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","volume":"144","author":"R Viotti","year":"2006","unstructured":"Viotti, R. et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: A nonrandomized trial. Ann. Intern. Med. 144, 724\u2013734. https:\/\/doi.org\/10.7326\/0003-4819-144-10-200605160-00006 (2006).","journal-title":"Ann. Intern. Med."},{"key":"5493_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.692655","author":"PSG Farani","year":"2021","unstructured":"Farani, P. S. G. et al. Treatment with suboptimal dose of benznidazole mitigates immune response molecular pathways in mice with chronic chagasic cardiomyopathy. Front. Cell. Infect. Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2021.692655 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"5493_CR74","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.4269\/ajtmh.16-0435","volume":"96","author":"G Brito","year":"2017","unstructured":"Brito, G. et al. Oral pentoxifylline associated with pentavalent antimony: A randomized trial for cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 96, 1155\u20131159. https:\/\/doi.org\/10.4269\/ajtmh.16-0435 (2017).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"5493_CR75","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1365-4632.2006.02867.x","volume":"45","author":"G Sadeghian","year":"2006","unstructured":"Sadeghian, G. & Nilforoushzadeh, M. A. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. Int. J. Dermatol. 45, 819\u2013821. https:\/\/doi.org\/10.1111\/j.1365-4632.2006.02867.x (2006).","journal-title":"Int. J. Dermatol."},{"key":"5493_CR76","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1086\/511643","volume":"44","author":"PR Machado","year":"2007","unstructured":"Machado, P. R. et al. Oral pentoxifylline combined with pentavalent antimony: A randomized trial for mucosal leishmaniasis. Clin. Infect. Dis. 44, 788\u2013793. https:\/\/doi.org\/10.1086\/511643 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"5493_CR77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","volume":"65","author":"HA Lessa","year":"2001","unstructured":"Lessa, H. A. et al. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am. J. Trop. Med. Hyg. 65, 87\u201389. https:\/\/doi.org\/10.4269\/ajtmh.2001.65.87 (2001).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"5493_CR78","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurjhf\/hfn040","volume":"11","author":"SM Shaw","year":"2009","unstructured":"Shaw, S. M., Shah, M. K., Williams, S. G. & Fildes, J. E. Immunological mechanisms of pentoxifylline in chronic heart failure. Eur. J. Heart Fail. 11, 113\u2013118. https:\/\/doi.org\/10.1093\/eurjhf\/hfn040 (2009).","journal-title":"Eur. J. Heart Fail."},{"key":"5493_CR79","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00042560-199512000-00004","volume":"10","author":"M Heinkelein","year":"1995","unstructured":"Heinkelein, M., Schneider-Schaulies, J., Walker, B. D. & Jassoy, C. Inhibition of cytotoxicity and cytokine release of CD8+ HIV-specific cytotoxic T lymphocytes by pentoxifylline. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10, 417\u2013424. https:\/\/doi.org\/10.1097\/00042560-199512000-00004 (1995).","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"5493_CR80","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0162-3109(99)00186-1","volume":"46","author":"T Krakauer","year":"2000","unstructured":"Krakauer, T. Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. Immunopharmacology 46, 253\u2013261. https:\/\/doi.org\/10.1016\/s0162-3109(99)00186-1 (2000).","journal-title":"Immunopharmacology"},{"key":"5493_CR81","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5603\/CJ.a2017.0105","volume":"25","author":"N Sun","year":"2018","unstructured":"Sun, N. et al. Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment. Cardiol. J. 25, 268\u2013278. https:\/\/doi.org\/10.5603\/CJ.a2017.0105 (2018).","journal-title":"Cardiol. J."},{"key":"5493_CR82","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1159\/000484121","volume":"43","author":"X Wang","year":"2017","unstructured":"Wang, X., Zhang, Y., Wang, H., Zhao, G. & Fa, X. MicroRNA-145 aggravates hypoxia-induced injury by targeting Rac1 in H9c2 cells. Cell. Physiol. Biochem. 43, 1974\u20131986. https:\/\/doi.org\/10.1159\/000484121 (2017).","journal-title":"Cell. Physiol. Biochem."},{"key":"5493_CR83","doi-asserted-by":"publisher","first-page":"H1813","DOI":"10.1152\/ajpheart.00709.2014","volume":"309","author":"K Higashi","year":"2015","unstructured":"Higashi, K. et al. MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy. Am. J. Physiol. Heart Circ. Physiol. 309, H1813\u2013H1826. https:\/\/doi.org\/10.1152\/ajpheart.00709.2014 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"5493_CR84","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9880.1000e106","author":"A Shahzad","year":"2012","unstructured":"Shahzad, A. & Yin, X. MicroRNAs (miRNAs) based biomarkers for acute myocardial infarction (AMI) diagnosis. J. Clin. Exp. Cardiol. https:\/\/doi.org\/10.4172\/2155-9880.1000e106 (2012).","journal-title":"J. Clin. Exp. Cardiol."},{"key":"5493_CR85","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.20-0160","author":"L Tan","year":"2021","unstructured":"Tan, L., Liu, L., Yao, J. & Piao, C. miR-145-5p attenuates inflammatory response and apoptosis in myocardial ischemia\u2013reperfusion injury by inhibiting NOH-1. Exp. Anim. https:\/\/doi.org\/10.1538\/expanim.20-0160 (2021).","journal-title":"Exp. Anim."},{"key":"5493_CR86","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.26355\/eurrev_202012_24194","volume":"24","author":"FT Huangfu","year":"2020","unstructured":"Huangfu, F. T., Tang, L. Q., Wang, H. Q., Zhao, X. & Yang, M. MiR-145-5p promotes myocardial cell apoptosis in rats with myocardial infarction through PI3K\/Akt signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 24, 12904\u201312911. https:\/\/doi.org\/10.26355\/eurrev_202012_24194 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"5493_CR87","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-017-2982-4","volume":"431","author":"M Yuan","year":"2017","unstructured":"Yuan, M. et al. MiR-145-5p regulates hypoxia-induced inflammatory response and apoptosis in cardiomyocytes by targeting CD40. Mol. Cell. Biochem. 431, 123\u2013131. https:\/\/doi.org\/10.1007\/s11010-017-2982-4 (2017).","journal-title":"Mol. Cell. Biochem."},{"key":"5493_CR88","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3389\/fmicb.2018.01341","volume":"9","author":"A Bonfim-Melo","year":"2018","unstructured":"Bonfim-Melo, A., Ferreira, E. R., Florentino, P. T. V. & Mortara, R. A. Amastigote synapse: The tricks of Trypanosoma cruzi extracellular amastigotes. Front. Microbiol. 9, 1341. https:\/\/doi.org\/10.3389\/fmicb.2018.01341 (2018).","journal-title":"Front. Microbiol."},{"key":"5493_CR89","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1073\/pnas.161298398","volume":"98","author":"MV Chuenkova","year":"2001","unstructured":"Chuenkova, M. V., Furnari, F. B., Cavenee, W. K. & Pereira, M. A. Trypanosoma cruzi trans-sialidase: A potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase\/Akt signaling. Proc. Natl. Acad. Sci. U.S.A. 98, 9936\u20139941. https:\/\/doi.org\/10.1073\/pnas.161298398 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"5493_CR90","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.micinf.2019.06.003","volume":"21","author":"BL Ferreira","year":"2019","unstructured":"Ferreira, B. L., Ferreira, \u00c9. R., Bonfim-Melo, A., Mortara, R. A. & Bahia, D. Trypanosoma cruzi extracellular amastigotes selectively trigger the PI3K\/Akt and Erk pathways during HeLa cell invasion. Microbes Infect. 21, 485\u2013489. https:\/\/doi.org\/10.1016\/j.micinf.2019.06.003 (2019).","journal-title":"Microbes Infect."},{"key":"5493_CR91","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.255687","volume":"134","author":"CA Najera","year":"2021","unstructured":"Najera, C. A., Batista, M. F., Meneghelli, I. & Bahia, D. Mixed signals\u2014How Trypanosoma cruzi exploits host-cell communication and signaling to establish infection. J. Cell Sci. 134, 255687. https:\/\/doi.org\/10.1242\/jcs.255687 (2021).","journal-title":"J. Cell Sci."},{"key":"5493_CR92","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12769","volume":"42","author":"LE Villanueva-Lizama","year":"2020","unstructured":"Villanueva-Lizama, L. E. et al. TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens. Parasite Immunol. 42, e12769. https:\/\/doi.org\/10.1111\/pim.12769 (2020).","journal-title":"Parasite Immunol."},{"key":"5493_CR93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-4939-9148-8_15","volume":"1955","author":"LRP Ferreira","year":"1955","unstructured":"Ferreira, L. R. P. MicroRNA transcriptome profiling in heart of Trypanosoma cruzi-infected mice. Methods Mol. Biol. 1955, 203\u2013214. https:\/\/doi.org\/10.1007\/978-1-4939-9148-8_15 (1955).","journal-title":"Methods Mol. Biol."},{"key":"5493_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044907","volume":"7","author":"R Li","year":"2012","unstructured":"Li, R. et al. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H(2)O(2))-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS\u00a0One 7, e44907. https:\/\/doi.org\/10.1371\/journal.pone.0044907 (2012).","journal-title":"PLoS\u00a0One"},{"key":"5493_CR95","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.biopha.2018.03.173","volume":"103","author":"S Li","year":"2018","unstructured":"Li, S., Sun, W., Zheng, H. & Tian, F. MicroRNA-145 accelerates the inflammatory reaction through activation of NF-kappaB signaling in atherosclerosis cells and mice. Biomed. Pharmacother. 103, 851\u2013857. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.173 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"5493_CR96","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.vph.2018.11.006","volume":"112","author":"F Vacante","year":"2019","unstructured":"Vacante, F., Denby, L., Sluimer, J. C. & Baker, A. H. The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease. Vascul. Pharmacol. 112, 24\u201330. https:\/\/doi.org\/10.1016\/j.vph.2018.11.006 (2019).","journal-title":"Vascul. Pharmacol."},{"key":"5493_CR97","doi-asserted-by":"publisher","first-page":"402","DOI":"10.18632\/aging.100042","volume":"1","author":"D Bhaumik","year":"2009","unstructured":"Bhaumik, D. et al. MicroRNAs miR-146a\/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1, 402\u2013411. https:\/\/doi.org\/10.18632\/aging.100042 (2009).","journal-title":"Aging (Albany NY)"},{"key":"5493_CR98","first-page":"737","volume":"19","author":"RK Kutty","year":"2013","unstructured":"Kutty, R. K. et al. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. Mol. Vis. 19, 737\u2013750 (2013).","journal-title":"Mol. Vis."},{"key":"5493_CR99","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1590\/s0074-02762008005000006","volume":"103","author":"SG Andrade","year":"2008","unstructured":"Andrade, S. G., Magalhaes Ldos, A. & Pessina, D. H. Importance of TNF-alpha in the course of acute infection with Trypanosoma cruzi: Influence of its inhibition by pentoxifylline treatment. Mem. Inst. Oswaldo Cruz 103, 21\u201326. https:\/\/doi.org\/10.1590\/s0074-02762008005000006 (2008).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"5493_CR100","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1590\/s0036-46652008000200001","volume":"50","author":"AM Bilate","year":"2008","unstructured":"Bilate, A. M. & Cunha-Neto, E. Chagas disease cardiomyopathy: Current concepts of an old disease. Rev. Inst. Med. Trop. Sao Paulo 50, 67\u201374. https:\/\/doi.org\/10.1590\/s0036-46652008000200001 (2008).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"5493_CR101","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1590\/0074-02760140435","volume":"110","author":"MJ Pinazo","year":"2015","unstructured":"Pinazo, M. J. et al. Biomarkers of therapeutic responses in chronic Chagas disease: State of the art and future perspectives. Mem. Inst. Oswaldo Cruz 110, 422\u2013432. https:\/\/doi.org\/10.1590\/0074-02760140435 (2015).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"5493_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.601364","volume":"7","author":"A Shrivastava","year":"2020","unstructured":"Shrivastava, A., Haase, T., Zeller, T. & Schulte, C. Biomarkers for heart failure prognosis: Proteins, genetic scores and non-coding RNAs. Front. Cardiovasc. Med. 7, 601364. https:\/\/doi.org\/10.3389\/fcvm.2020.601364 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"5493_CR103","doi-asserted-by":"publisher","first-page":"18986","DOI":"10.1073\/pnas.0509535102","volume":"102","author":"C Kwon","year":"2005","unstructured":"Kwon, C., Han, Z., Olson, E. N. & Srivastava, D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc. Natl. Acad. Sci. U.S.A. 102, 18986\u201318991. https:\/\/doi.org\/10.1073\/pnas.0509535102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"5493_CR104","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijcard.2012.09.108","volume":"166","author":"R Zhang","year":"2013","unstructured":"Zhang, R. et al. Elevated plasma microRNA-1 predicts heart failure after acute myocardial infarction. Int. J. Cardiol. 166, 259\u2013260. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.108 (2013).","journal-title":"Int. J. Cardiol."},{"key":"5493_CR105","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb0309-228","volume":"11","author":"J Winter","year":"2009","unstructured":"Winter, J., Jung, S., Keller, S., Gregory, R. I. & Diederichs, S. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228\u2013234. https:\/\/doi.org\/10.1038\/ncb0309-228 (2009).","journal-title":"Nat. Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05493-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:04:09Z","timestamp":1669327449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05493-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05493-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1436"}}